The global precision dosing market is anticipated to project robust growth in the forecast period, 2017-2027, with an impressive CAGR value on account of increasing demands for the accurate administrations of drugs and medicine. The requirement of providing appropriate drug administration to the geriatric population is also driving the growth of the global precision dosing market in the upcoming five years.

Delivering the right dose of the right drug to the right patient at the right time is termed precision dosing. It is also termed as the individualized dosing that utilizes the drug attributes like narrow therapeutic index, pharmacokinetic/pharmacodynamic (PK/PD) variability, disease state characteristics, along patient-specific data to optimize the drug therapy. In simpler terms, the process is of providing the correct dosage of the drug to the patient such that it does not cause any adverse effect on the patient and works in beneficial ways rather than creating any side effects.

Advancement in Medicine

The Healthcare industry is an ever-growing and advancing industry. The increasing number of chronic diseases, adverse effects of the diseases, and widespread pandemic-causing diseases require fast and effective control, and these factors drive the growth of the global precision dosing market in the upcoming five years. Advancement in therapeutics is furthering the expected growth of the global precision dosing market. Therapies like curative therapeutics are often categorized as aggressive treatment. Curing cancer through chemotherapy is one of the major examples where patients suffer the negative impact of chemotherapy. It is necessary to understand the requirement of the patient and monitor their conditions consistently during such procedures and stop the treatment in case the treatment is causing more harm to the patient than their recoveries, and these factors are further aiding the growth of the global precision dosing market in the future five years.

Demand to Decrease Adverse Drug Reaction

Adverse Drug Reactions (ADR) are a major challenge in the healthcare sector. Due to the increasing complexity of the therapeutics, rising geriatric population, and increasing instances of multimorbidity, the ADRs are increasing. To get a grip over the increasing cases, precision dosing is a must and thus aids the growth of the global precision dosing market in the upcoming five years. As healthcare and malpractice costs continue to rise, adverse drug reactions are also increasing. Although hospitals and healthcare experts utilize the tactics of early apology, mediation, and arbitration in the medical arena, the best possible method is to create precision dosing methods and concerned monitoring to guarantee the best patient care and thereby substantiate the growth of the global precision dosing market in the future five years. Precision dosing of medicines confirms minimum chances of adverse effects of medicines and thus aids the market growth.

Technological Advancement Aids Market Growth

Extensive research and technological advancement are supporting the growth of the global precision dosing market in the future five years. Innovative ideas and precise drug administration devices are substantiating the futuristic growth of the global precision dosing market in the upcoming five years. Usage of model-informed precision dosing to improve the patient’s drug treatment outcomes is further aiding the growth of the global precision dosing market in the next five years. Gene therapy, precision medicine, curative therapies are advanced methods of disease treatment and prevention that consider individual variability in genes, environment, and lifestyle for each patient. Modeling and simulation are used to account for individual variability in drug reactions and is an effective tool to determine the drug dose that maximizes the therapeutic benefit for the patient while also reducing the risks of any severe drug reactions.


Click here to download the sample

Market Segmentation

The global precision dosing market is segmented on the basis of patient type, tools, software, drug class, competitional landscape, and regional distribution. Based on patient type, the market is further fragmented into pediatrics, geriatrics, patients on polypharmacy, patients with end-organ dysfunction, and others. On the basis of tools, the market is bifurcated into physiologically-based pharmacokinetic (PBPK) modeling and non-linear mixed-effects (NLME) modeling. Based on software, the market is segmented into web-based and desktop-based. On the basis of drug class, the market is differentiated among antibiotics, antimycotics, immunosuppressives, antiepileptics, antitumoral drugs, antidepressants, and others. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among Asia-Pacific region, North American region, European region, South American region, and the Middle East & African region.

Company Profiles

InsightRX Nova, DoseMeRx (Tabula Rasa HealthCare (TRHC)), AEGIRBIO AB, MwPharm ++, TUCUXI Global Solution Pvt Ltd, Healthware, Inc. (PrecisePK), AutoKinetics, BestDose, Optimum Dosing Strategies (ID-ODS), NextDose, are among the major market players in the global platform that lead the market growth of the global precision dosing market.

Attribute

Details

Base Year

2021

Historical Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

·         Patient Type

·         Tools

·         Software

·         Drug Class

Regional Scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Country Scope

United States; Mexico; Canada; China; India; Japan; South Korea; Australia; Germany; France; United Kingdom; Spain; Italy; Saudi Arabia; UAE; South Africa; Brazil; Argentina; Colombia

Key Companies Profiled

InsightRX Nova, DoseMeRx (Tabula Rasa HealthCare (TRHC)), AEGIRBIO AB, MwPharm ++, TUCUXI Global Solution Pvt Ltd, Healthware, Inc. (PrecisePK), AutoKinetics, BestDose, Optimum Dosing Strategies (ID-ODS), NextDose

Customization Scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, global precision dosing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Precision Dosing Market, By Patient Type:
    • Pediatrics
    • Geriatrics
    • Patients on Polypharmacy
    • Patients with End Organ Dysfunction
    • Others
  • Precision Dosing Market, By Tools:
    • Physiologically-Based Pharmacokinetic (PBPK) Modeling
    • Non-Linear Mixed Effects (NLME) Modeling
  • Precision Dosing Market, By Software:
    • Web-Based
    • Desktop-Based
  • Precision dosing Market, By Drug Class:
    • Antibiotics
    • Antimycotics
    • Immunosuppressives
    • Antiepileptics
    • Antitumoral Drugs
    • Antidepressants
    • Others
  • Precision Dosing Market, By Region:
    • North America
      • United States
      • Mexico
      • Canada
    • Europe
      • France
      • Germany
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • India
      • Japan
      • South Korea
      • Australia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global precision dosing market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Precision Dosing Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com  

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Precision Dosing Market

4.    Executive Summary

5.    Voice of Customer

5.1.  Product/Service Awareness

5.2.  Brand Awareness

5.3.  Popular Drug Classes for Precision Dosing

6.    Global Precision Dosing Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Patient Type (Pediatrics, Geriatrics, Patients on Polypharmacy, Patients with End Organ Dysfunction, Others)

6.2.2.     By Tools (Physiologically-Based Pharmacokinetic (PBPK) Modeling v/s Non-Linear Mixed Effects (NLME) Modeling)

6.2.3.     By Software (Web-Based v/s Desktop-Based)

6.2.4.     By Drug Class (Antibiotics, Antimycotics, Immunosuppressives, Antiepileptics, Antitumoral Drugs, Antidepressants, Others)

6.2.5.     By Region

6.2.6.     By Company (2021)

6.3.  Product Market Map

7.    North America Precision Dosing Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Patient Type

7.2.2.     By Tools

7.2.3.     By Software

7.2.4.     By Drug Class

7.2.5.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Precision Dosing Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Patient Type

7.3.1.2.2.             By Tools

7.3.1.2.3.             By Software

7.3.1.2.4.             By Drug Class

7.3.2.     Mexico Precision Dosing Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Patient Type

7.3.2.2.2.             By Tools

7.3.2.2.3.             By Software

7.3.2.2.4.             By Drug Class

7.3.3.     Canada Precision Dosing Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Patient Type

7.3.3.2.2.             By Tools

7.3.3.2.3.             By Software

7.3.3.2.4.             By Drug Class

8.    Europe Precision Dosing Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Patient Type

8.2.2.     By Tools

8.2.3.     By Software

8.2.4.     By Drug Class

8.2.5.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France Precision Dosing Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Patient Type

8.3.1.2.2.             By Tools

8.3.1.2.3.             By Software

8.3.1.2.4.             By Drug Class

8.3.2.     United Kingdom Precision Dosing Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Patient Type

8.3.2.2.2.             By Tools

8.3.2.2.3.             By Software

8.3.2.2.4.             By Drug Class

8.3.3.     Italy Precision Dosing Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Patient Type

8.3.3.2.2.             By Tools

8.3.3.2.3.             By Software

8.3.3.2.4.             By Drug Class

8.3.4.     Germany Precision Dosing Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Patient Type

8.3.4.2.2.             By Tools

8.3.4.2.3.             By Software

8.3.4.2.4.             By Drug Class

8.3.5.     Spain Precision Dosing Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Patient Type

8.3.5.2.2.             By Tools

8.3.5.2.3.             By Software

8.3.5.2.4.             By Drug Class

9.    Asia-Pacific Precision Dosing Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Patient Type

9.2.2.     By Tools

9.2.3.     By Software

9.2.4.     By Drug Class

9.2.5.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China Precision Dosing Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Patient Type

9.3.1.2.2.             By Tools

9.3.1.2.3.             By Software

9.3.1.2.4.             By Drug Class

9.3.2.     India Precision Dosing Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Patient Type

9.3.2.2.2.             By Tools

9.3.2.2.3.             By Software

9.3.2.2.4.             By Drug Class

9.3.3.     Japan Precision Dosing Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Patient Type

9.3.3.2.2.             By Tools

9.3.3.2.3.             By Software

9.3.3.2.4.             By Drug Class

9.3.4.     South Korea Precision Dosing Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Patient Type

9.3.4.2.2.             By Tools

9.3.4.2.3.             By Software

9.3.4.2.4.             By Drug Class

9.3.5.     Australia Precision Dosing Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Patient Type

9.3.5.2.2.             By Tools

9.3.5.2.3.             By Software

9.3.5.2.4.             By Drug Class

10.  South America Precision Dosing Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Patient Type

10.2.2.  By Tools

10.2.3.  By Software

10.2.4.  By Drug Class

10.2.5.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Precision Dosing Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Patient Type

10.3.1.2.2.           By Tools

10.3.1.2.3.           By Software

10.3.1.2.4.           By Drug Class

10.3.2.  Argentina Precision Dosing Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Patient Type

10.3.2.2.2.           By Tools

10.3.2.2.3.           By Software

10.3.2.2.4.           By Drug Class

10.3.3.  Colombia Precision Dosing Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Patient Type

10.3.3.2.2.           By Tools

10.3.3.2.3.           By Software

10.3.3.2.4.           By Drug Class

11.  Middle East and Africa Precision Dosing Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Patient Type

11.2.2.  By Tools

11.2.3.  By Software

11.2.4.  By Drug Class

11.2.5.  By Country

11.3.              MEA: Country Analysis

11.3.1.  South Africa Precision Dosing Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Patient Type

11.3.1.2.2.           By Tools

11.3.1.2.3.           By Software

11.3.1.2.4.           By Drug Class

11.3.2.  UAE Precision Dosing Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Patient Type

11.3.2.2.2.           By Tools

11.3.2.2.3.           By Software

11.3.2.2.4.           By Drug Class

11.3.3.  Saudi Arabia Precision Dosing Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Patient Type

11.3.3.2.2.           By Tools

11.3.3.2.3.           By Software

11.3.3.2.4.           By Drug Class

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends and Developments

14.  Competitive Landscape

14.1.              InsightRX Nova

14.2.              DoseMeRx (Tabula Rasa HealthCare (TRHC))

14.3.              AEGIRBIO AB

14.4.              MwPharm ++

14.5.              TUCUXI Global Solution Pvt Ltd

14.6.              Healthware, Inc. (PrecisePK)

14.7.              AutoKinetics

14.8.              BestDose

14.9.              Optimum Dosing Strategies (ID-ODS)

14.10.            NextDose

 15. Strategic Recommendations

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com